Accumulating evidences have shown that omentin is a novel link between inflammation, diabetes, obesity, and cardiovascular disease, and probing its role may benefit patients with metabolic syndromes [11, 12]. The gene discussed is ITLN1; the disease is cardiovascular disorder.